Finance

Lists
AGMB:NASDAQ
Agomab Therapeutics NV
$14.50
+7.41%
(+1.00) 1D
Aug 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AGMB...
Open
$13.62
High
$14.50
Low
$13.15
Mkt. cap
714.10M
Avg. vol.
86.26K
Volume
367.40K
52-wk high
$17.82
52-wk low
$8.75
EPS
-$1.48
No. of employees
62
Open
$13.62
High
$14.50
Low
$13.15
Mkt. cap
714.10M
Avg. vol.
86.26K
Volume
367.40K
52-wk high
$17.82
52-wk low
$8.75
EPS
-$1.48
No. of employees
62
News stories
From sources across the web
About Agomab Therapeutics NV
CEO-
Employees62
Founded2017
Headquarters-
SectorPharmaceutical industry
Websiteagomab.com
Analyst ratings
Based on 3 analysts giving stock ratings to AGMB in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AGMB in the last 3 months.
Highest
Current $14.50
$35.00 (+141.38%)
Average
$32.33 (+122.97%)
Lowest
$28.00 (+93.10%)
Analyst
Recommendation
Action
Price target
Projected
Date
Judah Frommer
Morgan Stanley
Buy
Reiterated
$28.00
+93.1%
08/03/2026
William Wood
B. Riley Securities
Buy
Initiated
$34.00
+134.5%
07/23/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$35.00
+141.4%
07/22/2026
Anupam Rama
J.P. Morgan
Buy
Initiated
$32.00
+120.7%
03/03/2026
Thomas Smith
Leerink Partners
Buy
Initiated
$36.00
+148.3%
03/03/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Dec 2024
Dec 2025
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
10.73M
13.86M
Total research and development expenses
-
-
Selling, general, and admin expenses
1.47M
3.17M
Operating expense
11.81M
16.53M
Total operating expenses
11.81M
16.53M
Operating income
-11.81M
-16.53M
Other non operating income
-309.00K
-1.54M
EBT including unusual items
-11.73M
-17.40M
EBT excluding unusual items
-11.73M
-17.40M
Income tax expense
4.00K
-
Effective tax rate
-0.03%
-
Other operating expenses
-383.00K
-506.00K
Net income
-11.73M
-17.40M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
626.00K
720.00K
Interest expense
-
-
Net interest expenses
626.00K
720.00K
Depreciation and amortization charges
-
-
EBITDA
-11.80M
-16.51M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps